Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Aragon

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Kidney360|September 21, 2022
Hidden Costs Associated with Conversion from Peritoneal Dialysis to HemodialysisEric D Weinhandl, Tonya L Saffer, Michael Aragon
The International Journal of Artificial Organs|May 5, 2025
Utility of a water-sparing approach for reducing dialysate flow rates in hospitalized patients with kidney failureAmay Parikh, Kirsten Drake, Craig Woda, et al.
Clinical Nephrology|April 30, 2025
Effect of lower dialysate flow rates on quality of life and metabolic parameters in hemodialysisGeorge Coritsidis, Craig Woda, Demetrios Papademetriou, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|August 28, 2020
Patient-reported outcomes from the investigational device exemption study of the Tablo hemodialysis systemGlenn M Chertow, Luis Alvarez, Troy J Plumb, et al.
BMC Nephrology|October 22, 2022
Extension of Tablo TrEatmeNt Duration (XTEND) study: successful 24 h prolonged therapy with Tablo in critical patientsTahir Zaman, Kasadi Moore, Jennifer Jellerson, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Kidney360|September 21, 2022
Hidden Costs Associated with Conversion from Peritoneal Dialysis to HemodialysisEric D Weinhandl, Tonya L Saffer, Michael Aragon
The International Journal of Artificial Organs|May 5, 2025
Utility of a water-sparing approach for reducing dialysate flow rates in hospitalized patients with kidney failureAmay Parikh, Kirsten Drake, Craig Woda, et al.
Clinical Nephrology|April 30, 2025
Effect of lower dialysate flow rates on quality of life and metabolic parameters in hemodialysisGeorge Coritsidis, Craig Woda, Demetrios Papademetriou, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|August 28, 2020
Patient-reported outcomes from the investigational device exemption study of the Tablo hemodialysis systemGlenn M Chertow, Luis Alvarez, Troy J Plumb, et al.
BMC Nephrology|October 22, 2022
Extension of Tablo TrEatmeNt Duration (XTEND) study: successful 24 h prolonged therapy with Tablo in critical patientsTahir Zaman, Kasadi Moore, Jennifer Jellerson, et al.
Pageof 1